ChemicalBook > CAS DataBase List > Avasimibe

Avasimibe

Product Name
Avasimibe
CAS No.
166518-60-1
Chemical Name
Avasimibe
Synonyms
CS-90;CI-1011;avasimibe;PD 148515;Ava Maibu;Avasimibe, >=98%;Avasimibe(CI-1011);Avasimibe USP/EP/BP;PD-148515|||CI-1011;Avasimibe Solution, 100ppm
CBNumber
CB3854950
Molecular Formula
C29H43NO4S
Formula Weight
501.72
MOL File
166518-60-1.mol
More
Less

Avasimibe Property

Melting point:
178-180° (Lee); mp 169.5-170.4° (Dozeman)
Density 
1.072±0.06 g/cm3(Predicted)
storage temp. 
room temp
solubility 
DMSO: ≥40mg/mL
form 
powder
pka
1.97±0.70(Predicted)
color 
white to tan
InChIKey
PTQXTEKSNBVPQJ-UHFFFAOYSA-N
More
Less

Safety

WGK Germany 
3
HS Code 
2935909099
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
PZ0190
Product name
Avasimibe
Purity
≥98% (HPLC)
Packaging
5mg
Price
$129
Updated
2024/03/01
Sigma-Aldrich
Product number
PZ0190
Product name
Avasimibe
Purity
≥98% (HPLC)
Packaging
25mg
Price
$309.6
Updated
2024/03/01
Cayman Chemical
Product number
18129
Product name
Avasimibe
Purity
≥98%
Packaging
5mg
Price
$49
Updated
2024/03/01
Cayman Chemical
Product number
18129
Product name
Avasimibe
Purity
≥98%
Packaging
10mg
Price
$77
Updated
2024/03/01
Cayman Chemical
Product number
18129
Product name
Avasimibe
Purity
≥98%
Packaging
25mg
Price
$168
Updated
2024/03/01
More
Less

Avasimibe Chemical Properties,Usage,Production

Uses

Avasimibe has been used as an inhibitor of acyl-coenzyme A: cholesterol acyltransferase (ACAT) in Huh7.5.1 cells for testing its combination with direct-acting antivirals (DAAs) and to test its effect on lipid droplet accumulation in acidosis-adapted cancer cells. It may be used as an inhibitor of ACAT to assess cholesterol esterification in Trypanosoma cruzi.

Uses

Avasimibe is a selective inhibitor of Cholesterol Acyltransferase 1 and CYP2C9. Avasimibe is known to induce apoptosis of glioma cell lines as a model of glioblastoma.

Definition

ChEBI: Avasimibe is a monoterpenoid.

Biological Activity

avasimibe is an orally bioavailable inhibitor of the acyl coenzyme a: cholesterol acyltransferase (acat) with ic50 value of 60nm [1].avasimibe is developed from a strategy to design acat inhibitors with improved bioavailability. it also has solution stability at acidic ph. in the in vitro assay, the ic50 value is dependent on the concentration of microsomes, the amount of membrane available for adsorption as well as the presence of bsa. the treatment of avasimibe during the process of lipid loading causes a concentration-dependent reduction in cellular cholesteryl ester content. this reduction is not accompanied by the accumulation of intracellular free cholesterol, indicating a better safety profile for avasimibe than other acat inhibitors. avasimibe can also reduce the synthesis and secretion of apo b 100 (a component of vldl) in hepg2 cells. in addition, avasimibe can increase the total bile acid synthesis in rat hepatocytes at the concentration of 3μm [1].apart from the antiatherosclerotic efficacy, avasimibe is also found to take participate in the modulation of app trafficking. it can delay and reduce the maturation of app, limiting the availability of app holoprotein for aβ-generatiion [2].

Biochem/physiol Actions

Avasimibe (CI-1011) is an orally bioavailable Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) inhibitor. It was originally developed as an antilepic drug, and was shown to significantly reduce plasma total triglyceride and VLDL-cholesterol, but later clinical trials were disappointing. ACAT has also been investigated as a potential therapeutic target for Alzheimer′s disease. Recent studies have looked at the effects of avasimibe in reducing amyloid pathology by limiting generation and increasing clearance of diffusible amyloid-beta (Abeta).

target

ACAT

storage

Store at +4°C

References

[1] llaverías g, laguna jc, alegret m. pharmacology of the acat inhibitor avasimibe (ci-1011). 2003 spring;21(1):33-50.
[2] huttunen hj, peach c, bhattacharyya r, barren c, pettingell w, hutter-paier b, windisch m, berezovska o, kovacs dm. inhibition of acyl-coenzyme a: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway. faseb j. 2009 nov;23(11):3819-28.

Avasimibe Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Avasimibe Suppliers

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Fax
86-10-82849933
Email
jkinfo@jkchemical.com
Country
China
ProdList
94657
Advantage
76
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Fax
021-58180499
Email
sales@BioChemBest.com
Country
China
ProdList
6005
Advantage
61
Dalian Meilun Biotech Co., Ltd.
Tel
0411-62910999 13889544652
Email
meilunui@163.com
Country
China
ProdList
4727
Advantage
58
Shanghai civi chemical technology co.,Ltd
Tel
86-21-34053660
Fax
86-21-34053661
Email
sale@labgogo.com
Country
China
ProdList
9865
Advantage
52
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Fax
010-65763397
Email
waley188@sohu.com
Country
China
ProdList
12335
Advantage
58
NCE Biomedical Co.,Ltd.
Tel
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
Fax
+86-27-87599188
Country
China
ProdList
1493
Advantage
55
Haoyuan Chemexpress Co., Ltd.
Tel
021-58950125
Fax
(86) 21-58955996
Email
info@chemexpress.com
Country
China
ProdList
7552
Advantage
61
UHN Shanghai Research & Development Co., Ltd.
Tel
021-58958002 18930822973
Fax
+86 (21) 5895-8628
Email
SALES@UHNSHANGHAI.COM
Country
China
ProdList
977
Advantage
58
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-400-6206333 18521732826
Fax
021-50323701
Email
market@aladdin-e.com
Country
China
ProdList
25003
Advantage
65
Wuhan Kaymke Chemical Co., Ltd.,
Tel
027-027-87342388 18086026008
Fax
027-87342388
Email
sales@kaymke.com
Country
China
ProdList
3881
Advantage
55
More
Less

View Lastest Price from Avasimibe manufacturers

Career Henan Chemical Co
Product
Avasimibe 166518-60-1
Price
US $1.00/g
Min. Order
200KG
Purity
99%
Supply Ability
2tons
Release date
2019-12-19

166518-60-1, AvasimibeRelated Search:


  • 1-[(2,6-DIISOPROPYLPHENOXYSULFONYL)AMINO]-2-(2,4,6-TRIISOPROPYLPHENYL)ETHANONE
  • Ava Maibu
  • CS-90
  • Avasimibe, >=98%
  • 2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate
  • [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid
  • PD 148515
  • avasimibe
  • n-(2,6-dipropan-2-ylphenoxy)sulfonyl-2-(2,4,6-tripropan-2-ylphenyl)acetamide
  • N-[(2,6-DIISOPROPYLPHENOXY)SULFONYL]-2-(2,4,6-TRIISOPROPYLPHENYL)ACETAMIDE
  • ((2,4,6-TRIS(1-METHYLETHYL)PHENYL)ACETYL)SULFAMICACID2,6-BIS(1-METHYLETHYL)PHENYLESTER
  • Avasimibe(CI-1011)
  • CI-1011
  • AVASIMIBE;CI-1011; PD 148515
  • Sulfamic acid,N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenylester
  • Avasimibe Solution, 100ppm
  • Avasimibe USP/EP/BP
  • 1-({[2,6-bis(propan-2-yl)phenoxy]sulfonyl}amino)-2-[2,4,6-tris(propan-2-yl)phenyl]ethan-1-one
  • PD-148515|||CI-1011
  • 166518-60-1
  • C29H43NO4S
  • Inhibitors